These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9074791)

  • 1. Iron and porphyria cutanea tarda.
    D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high fiber vegetable-fruit diet on the activity of liver damage and serum iron level in porphyria cutanea tarda (PCT).
    Dabrowska E; Jabłońska-Kaszewska I; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():282-6. PubMed ID: 12211737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
    Okano J; Horie Y; Kawasaki H; Kondo M
    Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
    Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
    Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda, hepatitis C virus and selected symptoms of cholestasis.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Podlaska M; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():185-9. PubMed ID: 12211717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment].
    Bolewska B; Wojtacha A; Juszczyk J; Przedwojewski M
    Pol Merkur Lekarski; 2005 May; 18(107):552-5. PubMed ID: 16161954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort.
    Muñoz-Santos C; Guilabert A; Moreno N; Gimenez M; Darwich E; To-Figueras J; Herrero C
    Br J Dermatol; 2011 Sep; 165(3):486-91. PubMed ID: 21564073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda.
    Lamoril J; Andant C; Bogard C; Puy H; Gouya L; Pawlotsky JM; Da Silva V; Soulé JC; Deybach JC; Nordmann Y
    Hepatology; 1998 Mar; 27(3):848-52. PubMed ID: 9500716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders.
    Rocchi E; Casalgrandi G; Masini A; Giovannini F; Ceccarelli D; Ferrali M; Marchini S; Ventura E
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):861-7. PubMed ID: 10669994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cascade testing of primary care blood samples with hyperferritinaemia identifies subjects with iron overload and porphyria cutanea tarda.
    Baddams EL; Degg T; Barth JH
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):499-502. PubMed ID: 24081184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.